Filing Details
- Accession Number:
- 0001209191-10-002897
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-12 12:00:00
- Reporting Period:
- 2010-01-11
- Filing Date:
- 2010-01-12
- Accepted Time:
- 2010-01-12 17:53:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
824068 | Ats Medical Inc | ATSI | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 411595629 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1437376 | Thaddeus Coffindaffer | 3905 Annapolis Lane N. Plymouth MN 55447 | Vice President Of Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-11 | 4,000 | $0.00 | 119,152 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-11 | 40 | $3.25 | 119,112 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-11 | 950 | $3.26 | 118,162 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-11 | 350 | $3.28 | 117,812 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2010-01-11 | 4,000 | $0.00 | 8,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,000 | 2007-01-10 | 2011-01-10 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $3.36 | 2013-08-06 | 100,000 | 100,000 | Direct | |
Common Stock | Stock Option (Right to Buy) | $3.80 | 2013-10-28 | 5,000 | 5,000 | Direct | |
Common Stock | Stock Option (Right to Buy) | $3.80 | 2013-12-19 | 20,000 | 20,000 | Direct | |
Common Stock | Restricted Stock Units | $0.00 | 2008-03-15 | 2012-03-15 | 45,000 | 45,000 | Direct |
Common Stock | Restricted Stock Units | $0.00 | 2008-03-15 | 2012-03-15 | 12,066 | 12,066 | Direct |
Common Stock | Restricted Stock Units | $0.00 | 2009-03-15 | 2013-03-15 | 70,103 | 70,103 | Direct |
Common Stock | Restricted Stock Units | $0.00 | 2009-07-30 | 2013-07-30 | 4,000 | 40,000 | Direct |
Common Stock | Restricted Stock Unit | $0.00 | 2010-03-15 | 2014-03-15 | 60,665 | 66,065 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2013-08-06 | 100,000 | 100,000 | Direct |
2013-10-28 | 5,000 | 5,000 | Direct |
2013-12-19 | 20,000 | 20,000 | Direct |
2012-03-15 | 45,000 | 45,000 | Direct |
2012-03-15 | 12,066 | 12,066 | Direct |
2013-03-15 | 70,103 | 70,103 | Direct |
2013-07-30 | 4,000 | 40,000 | Direct |
2014-03-15 | 60,665 | 66,065 | Direct |
Footnotes
- Includes shares held in Employee Stock Purchase Plan as of a plan date of April 30, 2009.
- Reflects an increase of 5,250 shares which have not been included on three Forms 4 filed between January 2009 and this filing. A Form 4 relating to vesting on January 12, 2009 of restricted stock units has been filed concurently with this filing.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2009.
- Fully vested.
- 1 unit for 1 share of Common Stock
- Vests in 20% annual cumulative installments beginning the date shown.
- Represents last vesting date.
- Vests in 25% annual cumulative installments beginning the date shown.
- Vests in 20% annual cumulative installments starting on the date shown; in the second year remaining vesting is subject to acceleration if certain performance criteria are met.